CAS
STXS icon

CTC Alternative Strategies’s Stereotaxis STXS Stock Holding History

CTC Alternative Strategies’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,600
Closed -$43.3K – 268
2024
Q1 		$43.3K Buy
+16,600
New +$39.5K 0.03% 122

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

CTC Alternative Strategies's STXS Position: Q2 2024 in Review

CTC Alternative Strategies sold out of Stereotaxis (STXS) in Q2 2024, closing a stake of 16,600 shares — an estimated $43.3K sold.

CTC Alternative Strategies first reported a position in STXS in Q1 2024 and held it in 1 quarter. The position peaked at $43.3K in Q1 2024. 73 funds tracked by Wall St. Rank hold STXS as of Q2 2024.

  • CTC Alternative Strategies reported no remaining Stereotaxis position as of Q2 2024 after selling out during the quarter.
  • CTC Alternative Strategies sold 16,600 Stereotaxis shares in Q2 2024, an estimated $43.3K.
  • CTC Alternative Strategies first reported a position in Stereotaxis in Q1 2024 and held it in 1 quarter.
  • CTC Alternative Strategies's Stereotaxis position peaked at $43.3K in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2024.

Based on CTC Alternative Strategies's 13F filing for Q2 2024, filed 2 Aug 2024.